World's Best Scientists 2026 revealed!
Heiner Wedemeyer

Heiner Wedemeyer

D-Index & Metrics

Microbiology

D-Index
105
Citations
44108
World Ranking
309
National Ranking
20

Medicine

D-Index
108
Citations
49139
World Ranking
5944
National Ranking
338

Heiner Wedemeyer publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Heiner Wedemeyer sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 265 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 234 scientists 205–214 publications: 208 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 860 publications — 100th percentile

100% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Heiner Wedemeyer D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Heiner Wedemeyer sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 112 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 123 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 94 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 105 D-Index — 94th percentile

94% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Heiner Wedemeyer is affiliated with Hannover Medical School in Germany and has an extensive body of research primarily focused on hepatology within the broader field of medicine. Their work spans numerous aspects of liver disease, including viral hepatitis and liver transplantation.

The scientist's research covers several main topics, which include:

  • Hepatitis C virus research
  • Liver Disease Diagnosis and Treatment
  • Hepatitis B Virus Studies
  • Liver Disease and Transplantation
  • Hepatitis Viruses Studies and Epidemiology
  • Liver Diseases and Immunity
  • Organ Transplantation Techniques and Outcomes

Wedemeyer's primary fields of study are within medicine, with subfields concentrating on hepatology, epidemiology, surgery, immunology, and infectious diseases.

Frequent publication venues for Wedemeyer's work include:

  • Journal of Hepatology
  • Zeitschrift für Gastroenterologie
  • Liver International
  • JHEP Reports
  • Journal of Viral Hepatitis

Among recent notable publications authored by Wedemeyer are:

  • "A Phase 3, Randomized Trial of Bulevirtide in Chronic Hepatitis D" (2023) published in New England Journal of Medicine
  • "Safety and efficacy of bulevirtide in combination with tenofovir disoproxil fumarate in patients with hepatitis B virus and hepatitis D virus coinfection (MYR202): a multicentre, randomised, parallel-group, open-label, phase 2 trial" (2022) published in The Lancet Infectious Diseases

Additional recent impactful papers in the broader field, co-authored by others, include:

  • "EASL recommendations on treatment of hepatitis C: Final update of the series" (2020) published in Journal of Hepatology
  • "EASL Clinical Practice Guidelines on hepatitis delta virus" (2023) published in Journal of Hepatology
  • "Prothrombotic immune thrombocytopenia after COVID-19 vaccination" (2021) published in Blood

Heiner Wedemeyer frequently collaborates with other researchers including Markus Cornberg, Benjamin Maasoumy, Katja Deterding, Pietro Lampertico, and Michael P. Manns, who are significant co-authors in related fields of hepatology and liver disease research.

Best Publications

  • Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study

    Sarah Blach;Stefan Zeuzem;Michael Manns;Ibrahim Altraif

  • ABT-450/r-Ombitasvir and Dasabuvir with Ribavirin for Hepatitis C with Cirrhosis

    Fred Poordad;Christophe Hezode;Roger Trinh;Kris V. Kowdley

  • EASL recommendations on treatment of hepatitis C: Final update of the series ☆

    Jean-Michel Pawlotsky;Francesco Negro;Alessio Aghemo;Marina Berenguer

  • Increased populations of regulatory T cells in peripheral blood of patients with hepatocellular carcinoma

    Lars A. Ormandy;Tina Hillemann;Heiner Wedemeyer;Michael P. Manns

  • Sustained Virologic Response and Clinical Outcomes in Patients with Chronic Hepatitis C and Advanced Fibrosis

    Bart J Veldt;E Jenny Heathcote;Heiner Wedemeyer;Juerg Reichen

  • Tremelimumab in combination with ablation in patients with advanced hepatocellular carcinoma.

    Austin G. Duffy;Susanna V. Ulahannan;Oxana Makorova-Rusher;Osama Rahma

  • Impaired Effector Function of Hepatitis C Virus-Specific CD8+ T Cells in Chronic Hepatitis C Virus Infection

    Heiner Wedemeyer;Xiao Song He;Michelina Nascimbeni;Anthony R. Davis

  • Myeloid Derived Suppressor Cells Inhibit Natural Killer Cells in Patients with Hepatocellular Carcinoma via the NKp30 Receptor

    Bastian Hoechst;Torsten Voigtlaender;Lars Ormandy;Jaba Gamrekelashvili

  • EASL Clinical Practice Guidelines on hepatitis E virus infection

    Harry R. Dalton;Nassim Kamar;Sally A. Baylis;Darius Moradpour

  • Hepatitis B surface antigen (HBsAg) levels in the natural history of hepatitis B virus (HBV)-infection: a European perspective.

    Jerzy Jaroszewicz;Jerzy Jaroszewicz;Beatriz Calle Serrano;Karsten Wursthorn;Katja Deterding

  • Hepatitis E virus infection.

    Nassim Kamar;Jacques Izopet;Nicole Pavio;Rakesh Aggarwal

  • Peginterferon plus adefovir versus either drug alone for hepatitis delta.

    Heiner Wedemeyer;Cihan Yurdaydìn;George N. Dalekos;Andreas Erhardt

  • Retreatment of HCV with ABT-450/r-ombitasvir and dasabuvir with ribavirin.

    Unknown

  • Epidemiology, pathogenesis and management of hepatitis D: update and challenges ahead

    Heiner Wedemeyer;Michael P. Manns

  • Glecaprevir–Pibrentasvir for 8 or 12 Weeks in HCV Genotype 1 or 3 Infection

    Stefan Zeuzem;Graham R Foster;Stanley Wang;Armen Asatryan

  • Hepatitis B surface antigen quantification: why and how to use it in 2011 - a core group report.

    Henry Lik-Yuen Chan;Alex Thompson;Michelle Martinot-Peignoux;Teerha Piratvisuth

  • Long-term efficacy of tenofovir monotherapy for hepatitis B virus-monoinfected patients after failure of nucleoside/nucleotide analogues†

    Florian van Bömmel;Robert A. de Man;Heiner Wedemeyer;Katja Deterding

  • Treatment of chronic hepatitis D with the entry inhibitor myrcludex B: First results of a phase Ib/IIa study

    Pavel Bogomolov;Alexander Alexandrov;Natalia Voronkova;Maria Macievich

  • Short-term antiviral efficacy of BILN 2061, a hepatitis C virus serine protease inhibitor, in hepatitis C genotype 1 patients.

    Holger Hinrichsen;Yves Benhamou;Heiner Wedemeyer;Markus Reiser

  • Hepatitis delta virus

    Unknown

  • Historical epidemiology of hepatitis C virus (HCV) in selected countries

    P. Bruggmann;T. Berg;A. L. H. Øvrehus;C. Moreno

  • Pathogenesis and treatment of hepatitis e virus infection.

    Heiner Wedemeyer;Sven Pischke;Michael P. Manns

  • Hepatitis E in Germany--an under-reported infectious disease.

    Sven Pischke;Patrick Behrendt;Claus-Thomas Bock;Wolfgang Jilg

Frequent Co-Authors

Michael P. Manns
Michael P. Manns Hannover Medical School
Markus Cornberg
Markus Cornberg Hannover Medical School
Stefan Zeuzem
Stefan Zeuzem Goethe University Frankfurt
Christoph Sarrazin
Christoph Sarrazin Goethe University Frankfurt
Hans L. Tillmann
Hans L. Tillmann East Carolina University
Harry L.A. Janssen
Harry L.A. Janssen Erasmus University Rotterdam
Stefan Mauss
Stefan Mauss Université Paris Cité
Sandra Ciesek
Sandra Ciesek Goethe University Frankfurt
Eike Steinmann
Eike Steinmann Ruhr University Bochum
Christian P. Strassburg
Christian P. Strassburg University Hospital Bonn

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring online degrees related to Microbiology can open doors to diverse career opportunities, even for those facing unique challenges. For instance, individuals curious about the best degree for felons highlight accessible programs that provide a fresh start in healthcare and science-related fields.

One promising path is becoming a functional nurse practitioner, blending microbiology knowledge with holistic patient care. This role requires specialized training but offers a dynamic and rewarding career in modern healthcare.

Beyond direct patient care, careers in medical coding and health information management are growing rapidly. Pursuing certification as a certified professional coder salary reflects a lucrative and stable career avenue tied to healthcare data accuracy and compliance.

Similarly, a role as a health information manager salary specialist combines microbiology insights and data management skills to optimize healthcare operations. Online degrees often prepare students for these essential functions, enhancing career flexibility and growth.

Best Scientists Citing Heiner Wedemeyer

Trending Scientists